isosakuranetin has been researched along with n,n-dimethylsphingenine in 1 studies
| Studies (isosakuranetin) | Trials (isosakuranetin) | Recent Studies (post-2010) (isosakuranetin) | Studies (n,n-dimethylsphingenine) | Trials (n,n-dimethylsphingenine) | Recent Studies (post-2010) (n,n-dimethylsphingenine) |
|---|---|---|---|---|---|
| 28 | 0 | 20 | 165 | 0 | 38 |
| Protein | Taxonomy | isosakuranetin (IC50) | n,n-dimethylsphingenine (IC50) |
|---|---|---|---|
| Lethal factor | Bacillus anthracis | 2.3 | |
| Sphingosine kinase 1 | Homo sapiens (human) | 4.5233 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Koivisto, A; Pertovaara, A; Wei, H | 1 |
1 other study(ies) available for isosakuranetin and n,n-dimethylsphingenine
| Article | Year |
|---|---|
Spinal mechanisms contributing to the development of pain hypersensitivity induced by sphingolipids in the rat.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Flavanones; Flavonoids; Glucosides; Hyperalgesia; Isoflavones; Male; Rats; Rats, Wistar; Sphingolipids; Sphingosine; Spinal Cord | 2021 |